Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
11/15/20216:00AMPR Newswire (US)AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/10/20218:30AMPR Newswire (US)AcelRx to Host Third Quarter 2021 Financial Results Call and Webcast on November 15, 2021NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/04/20217:30AMGlobeNewswire Inc.Adamis Announces Appointment of Meera Desai, Ph.D., to Board of DirectorsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/10/20213:19PMPR Newswire (US)AcelRx Pharmaceuticals to Participate in Two September Investor ConferencesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/30/20218:30AMPR Newswire (US)Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery EventNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/26/20218:30AMPR Newswire (US)Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery EventNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/25/20219:17AMTipRanksUnderstanding AcelRx Pharma’s Risk Factors Post Q2NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/18/20214:02PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/16/20214:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/16/20214:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/09/20218:30AMPR Newswire (US)AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/29/20214:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/14/20214:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/14/20218:30AMPR Newswire (US)AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S.NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/12/20218:32AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20215:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20219:33AMDow Jones NewsAcelRx in Agreement with FDA On Dsuvia Promotional Materials Warning LetterNASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/17/20218:30AMPR Newswire (US)AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional MaterialsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/01/20218:30AMPR Newswire (US)Rapid Discharge with Minimal PACU Opioids was Key Message During Presentation of DSUVIA® For Analgesia in Plastic Surgery Pr...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/26/20218:30AMPR Newswire (US)Presentation on the Use of DSUVIA® for Plastic Surgery Procedures Selected for "Best Papers" Session at the California Socie...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/20/20218:30AMPR Newswire (US)AcelRx Announces an Investigator-Initiated Study of DSUVIA® in the Emergency Department for Patients with Sickle Cell Diseas...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/17/20214:40PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/17/20214:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/17/20214:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports First Quarter 2021 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX